Literature DB >> 31144261

Ethnic Disparities in Adiposity: Focus on Non-alcoholic Fatty Liver Disease, Visceral, and Generalized Obesity.

Uchenna Agbim1, Rotonya M Carr2, Octavia Pickett-Blakely2, Sam Dagogo-Jack3.   

Abstract

PURPOSE OF REVIEW: Excessive adiposity has become a public health problem worldwide, contributing to the rise in obesity-related diseases and associated morbidity and mortality. This review details the relative significance of race/ethnicity as it pertains to adiposity and non-alcoholic fatty liver disease (NAFLD). RECENT
FINDINGS: Fat distribution remains a more reliable measure of adiposity than anthropometric measures, with visceral adipose tissue (VAT) associated with increased risk of cardiometabolic disease. While obesity is the most common risk factor for NAFLD, the racial/ethnic prevalence of obesity does not completely parallel NAFLD risk. Combating racial/ethnic disparities in obesity requires understanding differential risk among various groups. Hispanics are disproportionally impacted by NAFLD and have high rates of obesity, VAT, and insulin resistance (IR). This contrasts with Blacks, who have high prevalence of obesity and IR, accompanied by a paradoxically favorable lipid profile and low prevalence of VAT and NAFLD. Many features of adiposity and NAFLD are mediated by genetic and environmental factors, the latter being modifiable and the focus of interventions.

Entities:  

Keywords:  Ethnicity; Health disparities; NAFLD; Obesity; Race; Visceral adiposity

Year:  2019        PMID: 31144261      PMCID: PMC6662200          DOI: 10.1007/s13679-019-00349-x

Source DB:  PubMed          Journal:  Curr Obes Rep        ISSN: 2162-4968


  16 in total

1.  Cardiometabolic Health Outcomes Associated With Discordant Visceral and Liver Fat Phenotypes: Insights From the Dallas Heart Study and UK Biobank.

Authors:  Sanaa Tejani; Cody McCoy; Colby R Ayers; Tiffany M Powell-Wiley; Jean-Pierre Després; Jennifer Linge; Olof Dahlqvist Leinhard; Mikael Petersson; Magnus Borga; Ian J Neeland
Journal:  Mayo Clin Proc       Date:  2021-09-28       Impact factor: 7.616

2.  MRI Based Validation of Abdominal Adipose Tissue Measurements From DXA in Postmenopausal Women.

Authors:  Jennifer W Bea; Zhao Chen; Robert M Blew; Jennifer Skye Nicholas; Shawna Follis; Victoria L Bland; Ting-Yuan David Cheng; Heather M Ochs-Balcom; Jean Wactawski-Wende; Hailey R Banack; Marian L Neuhouser; Deepika Laddu; Marcia L Stefanick; Jane A Cauley; Bette Caan; Meryl S LeBoff; Rowan T Chlebowski; Andrew O Odegaard
Journal:  J Clin Densitom       Date:  2021-07-29       Impact factor: 2.963

3.  Determining whether ethnic minorities with severe obesity face a disproportionate risk of serious disease and death from COVID-19: outcomes from a Southern California-based retrospective cohort study.

Authors:  Hemesh Mahesh Patel; Shefali Khandwala; Poonam Somani; Qiaowu Li; Stephanie Tovar; Alejandra Montano
Journal:  BMJ Open       Date:  2022-06-29       Impact factor: 3.006

4.  Arsenic and birth outcomes in a predominately lower income Hispanic pregnancy cohort in Los Angeles.

Authors:  Caitlin G Howe; Shohreh F Farzan; Erika Garcia; Thomas Jursa; Ramsunder Iyer; Kiros Berhane; Thomas A Chavez; Tahlia L Hodes; Brendan H Grubbs; William E Funk; Donald R Smith; Theresa M Bastain; Carrie V Breton
Journal:  Environ Res       Date:  2020-02-27       Impact factor: 6.498

5.  Healthy dietary patterns and metabolic dysfunction-associated fatty liver disease in less-developed ethnic minority regions: a large cross-sectional study.

Authors:  Xiaofen Xie; Bing Guo; Ting Chen; Baima Kangzhuo; Xing Zhao; Xiong Xiao; Jianzhong Yin; Ziyun Wang; Xiaoman Jiang; Jingzhong Li; Lu Long; Junmin Zhou; Ning Zhang; Yuan Zhang
Journal:  BMC Public Health       Date:  2022-01-17       Impact factor: 3.295

Review 6.  Heterogeneity of non-alcoholic fatty liver disease: Implications for clinical practice and research activity.

Authors:  Partha Pal; Rajan Palui; Sayantan Ray
Journal:  World J Hepatol       Date:  2021-11-27

7.  Waist-to-height ratio, an optimal anthropometric indicator for metabolic dysfunction associated fatty liver disease in the Western Chinese male population.

Authors:  Jinwei Cai; Cuiting Lin; Shuiqing Lai; Yingshan Liu; Min Liang; Yingfen Qin; Xinghuan Liang; Aihua Tan; Yong Gao; Zheng Lu; Chunlei Wu; Shengzhu Huang; Xiaobo Yang; Haiying Zhang; Jian Kuang; Zengnan Mo
Journal:  Lipids Health Dis       Date:  2021-10-27       Impact factor: 3.876

8.  Cardiovascular outcomes of antidiabetes medications by race/ethnicity: A systematic review and meta-analysis.

Authors:  Xiaoling Cai; Chu Lin; Wenjia Yang; Sam Dagogo-Jack; Linong Ji
Journal:  J Diabetes Complications       Date:  2021-06-27       Impact factor: 3.219

9.  Validating a non-invasive, ALT-based non-alcoholic fatty liver phenotype in the million veteran program.

Authors:  Marina Serper; Marijana Vujkovic; David E Kaplan; Rotonya M Carr; Kyung Min Lee; Qing Shao; Donald R Miller; Peter D Reaven; Lawrence S Phillips; Christopher J O'Donnell; James B Meigs; Peter W F Wilson; Rachel Vickers-Smith; Henry R Kranzler; Amy C Justice; John M Gaziano; Sumitra Muralidhar; Saiju Pyarajan; Scott L DuVall; Themistocles L Assimes; Jennifer S Lee; Philip S Tsao; Daniel J Rader; Scott M Damrauer; Julie A Lynch; Danish Saleheen; Benjamin F Voight; Kyong-Mi Chang
Journal:  PLoS One       Date:  2020-08-25       Impact factor: 3.240

10.  Clinical characterization of data-driven diabetes subgroups in Mexicans using a reproducible machine learning approach.

Authors:  Omar Yaxmehen Bello-Chavolla; Jessica Paola Bahena-López; Arsenio Vargas-Vázquez; Neftali Eduardo Antonio-Villa; Alejandro Márquez-Salinas; Carlos A Fermín-Martínez; Rosalba Rojas; Roopa Mehta; Ivette Cruz-Bautista; Sergio Hernández-Jiménez; Ana Cristina García-Ulloa; Paloma Almeda-Valdes; Carlos Alberto Aguilar-Salinas
Journal:  BMJ Open Diabetes Res Care       Date:  2020-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.